Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in Romania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: Romania Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20081
20092
20102
20113
20124
20132
20141
20161
20171
20181
20193
20232
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated6
Active, not recruiting3
Recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
AstraZeneca4
Eli Lilly and Company4
Novartis Pharmaceuticals4
Pfizer2
United Therapeutics2
Alnylam Pharmaceuticals1
Amarin Pharma Inc.1
Amgen1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases31
Myocardial Infarction8
Stroke8
Diabetes Mellitus, Type 27
Hypertension7
Heart Diseases6
Acute Coronary Syndrome5
Atherosclerosis5
Coronary Artery Disease4
Coronary Disease3

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.